Sunteți pe pagina 1din 12

ntdeisaHAd

U n i t e d S It a
o s phiet as live
- a csq uMi raerdke
I nt f e c t i o n s
P r e veFo
n t re
i o nc aMsatr &
k eO
t O
p pppoorrttuunnii t i eess,, 22001200- 2 0 2 0
Pharma & Healthcare Consultants

Research Methodology
US Hospital-acquired Infections
Prevention Market Opportunities, 2020

Primary Research

Secondary Research
Government websites
Company annual reports, white
papers, investor presentations and
financial reports

Identifying Key Opinion Leaders


Questionnaire Design
In-depth Interviews
Coverage across Value Chain market
Preliminary Data Mining

Qualitative and Quantitative research

Data Validation, Analysis and Interpretation


Data validation through Primary & Secondary outreach, data analysis and
interpretation of key findings

Market Estimation & Forecasting


Bottom-Up or Top-down approach for Market size estimation
Historical trend examination

Impact analysis of drivers and challenges to

market growth

Statistical evaluation to develop the actual forecast


CAGR (2015E-2020F): XX%

2
2015E 2016F 2017F 2018F 2019F 2020F

Pharmaion

Research Methodology
Baseline Methodology:
For the study of the United States hospital-acquired infections prevention market, Pharmaion has gathered
information through an exhaustive search of credible databases prudently evaluated all the collected information
and presented it in the most accurate and detailed manner.

Primary Sources
Key Stakeholders:
Product/Brand Managers

Business Development
Managers

Qualitative and
quantitative data
from company
website, financial
reports, research
articles, designed
questionnaires
etc.

In-depth
interviews of key
stakeholders of
major companies

Regional Mangers
Regulatory Affairs Personnel
Marketing & Sales Managers
Head of Patient Support
Programme

Secondary Sources

Data
Triangulation
(Data
validation
through cross
verification
from primary
& secondary
sources)

Analysis of Data from credible


sources:
Centers for Disease Control
and Prevention (CDC)
American Cancer Institute
American Hospital Directory
Substantial data points for analysis,
interpretation and market size estimation

3
Pharmaion

Research Methodology
United States Hospital-acquired Infections Prevention Market - Market Size Estimation

Calculation of United
States Sterilization for
Hospital-acquired
Infections Prevention
Market Size

Calculation
of Subsegment
market size

Calculation
of United
States
Disinfection
for Hospitalacquired
Infections
Prevention
Market Size

Calculation of Sub- segment


market size

Total Market Size =


Sterilization Market
Size + Disinfection
Market Size

Bottom-up Approach

Top-down Approach

United States Hospital-acquired Infections Prevention market has been segmented into two categories:
Disinfection and Sterilization
Sterilization has been further categorized into three sub-segments: Equipment, Services, and
Consumables
Disinfection has been further classified into six sub segments: Disinfection Robots, Disinfectants,
Endoscope Reprocessors, Disinfectors, Wipes, and Personal-use Non-wovens.

Regional & Company


Market Size =
Respective Market
Share (from primary
and secondary
research) X Total
Market Value

4
Pharmaion

Ta b l e o f C o n t e n t s
S No.

Contents

1.

Hospital-acquired Infections Prevention Overview

2.

Research Methodology

3.

Analyst View

4.

Global Hospital-acquired Infections Prevention Market Overview

5.

United States Hospital-acquired Infections Prevention Market Outlook


5.1.

Market Size and Forecast


5.1.1.

5.2.

6.

Market Share & Forecast


5.2.1.

By Prevention Type

5.2.2.

By Region

5.2.3.

By Company

United States Sterilization for Hospital-acquired Infections Prevention Market Outlook


6.1.

Market Size and Forecast


6.1.1.

6.2.

By Value

Market Share & Forecast


6.2.1.

7.

By Value

By Type

United States Disinfection for Hospital-acquired Infections Prevention Market Outlook


7.1.

Market Size and Forecast


7.1.1.

7.2.

By Value

Market Share & Forecast


7.2.1.

By Type

5
Pharmaion

Ta b l e o f C o n t e n t s
S No.
8.

9.

10.

Contents
Market Dynamics
8.1.

Drivers

8.2.

Challenges

Market Trends & Developments


9.1.

UV Disinfecting Robots Future of Disinfection

9.2.

Plummeting Surgical Site Infections

9.3.

RFID Technology for Monitoring Hand Hygiene

9.4.

Gas Plasma Sterilization Technology

9.5.

Hospital Infection Prevention from Digital Technology

Regulatory Framework and Guidelines


10.1.

Deficit Reduction Act of 2005

10.2.

Guidelines

11.

United States Economic Profile

12.

Competitive Landscape
12.1.

Competition Benchmarking

12.2.

Company Profiles
12.2.1.

Steris Corporation

12.2.2.

Advanced Sterilization Products

12.2.3.

Getinge USA, Inc.

12.2.4.

3M Company

12.2.5.

Belimed

12.2.6.

Cantel Medical Corp.

6
Pharmaion

Ta b l e o f C o n t e n t s
S No.

Contents
12.2.7.

Halyard Health, Inc.

12.2.8.

Cisa America Inc.

12.2.9.

Cardinal Health, Inc.

12.2.10.

Tuttnauer USA Co. Ltd.

13.

Strategic Recommendations

14.

About Us & Disclaimer

7
Pharmaion

Industry Brief
United States Hospital-acquired Infections Prevention Market to Grow at Over 7% Until 2020
Growing incidence of hospital-acquired infections and stringent government policies to drive the United States
hospital-acquired infections prevention market through 2020
According to recently published Pharmaion report,United States Hospital-acquired Infections Prevention Market
Opportunities, 2010 - 2020, hospital-acquired infections prevention market in the United States is projected to
grow at a CAGR of over 7% during 2015 - 2020. Growth in the US hospital-acquired infections prevention market
can be attributed to growing incidence of hospital-acquired infections and rising prevalence of chronic diseases
among geriatric population. Moreover, implementation of stringent laws against hospitals with regards to hospitalacquired infections, under the Deficit Regulation Act, 2005,is also anticipated to drive demand for hospitalacquired infections prevention market in the United States during 2015 - 2020.
On the basis of prevention type, the market has been segmented into two categories, namely, sterilization and
disinfection. Among these categories, sterilization segment dominated the United States hospital-acquired
infections prevention market in 2014, and is anticipated to continue its dominance during forecast period on
account of its high efficiency and capability to clean and kill microorganisms in extreme corners of medical devices
used in diagnostic and treatment procedures. South region accounted for the largest share in the United States
hospital-acquired infections prevention market in 2014, followed by the Midwest, West and North-East regions.
With increasing adoption of UV disinfecting robots and RFID, a technology for monitoring hand hygiene, coupled
with growing adoption of gas plasma sterilization technology, the market for hospital-acquired infections
prevention market in the United States is anticipated to grow at a robust pace over the next five years. Moreover,
Office of Disease Prevention and Health Promotion (ODPHP) and US Department of Health and Human Services
(HHS) developed the National Action Plan to Prevent Health Care-Associated Infections: Road Map to
Elimination in 2009. This plan was focused to prevent hospital-acquired infections across all health care settings,
including acute care hospitals, ambulatory surgical centres, end-stage renal disease facilities and long-term care
facilities. said Mr. Karan Chechi, Research Director, with Pharmaion Consultants, a research based global
pharmaceutical and healthcare consulting firm.

8
Pharmaion

Hospital-acquired Infections Prevention Overview

Hospital-acquired Infections
Hospital-acquired infection, also known as nosocomial infection, is defined as an infection whose development
takes place in a favourable hospital environment, specifically those which are acquired by a patient during a
hospital visit and often develop among the hospital staff.
Hospital-acquired infections majorly leads to severe pneumonia and infections of bloodstream, urinary tract
and other parts of the body.
United States Hospital-acquired Infections Share, 2013

Abbreviations Used:
VAP, 20%

SSI, 20%

XXXX
XXXX
XXXX

CLABSI, 20%
CAUTI, 20%

XXXX
XXXX

HO-HCFA CDI,
20%

9
Pharmaion

Sample Data - Snapshot


North-East Region

United States Hospital-acquired Infections Prevention Market


Size, By Region, By Value, 2010-2014 (USD Million)

Midwest Region

2010 2011 2012 2013 2014


2010

2011

2012

2013

2014
United States Costs of Commonly Hospital-acquired

West Region

1
2010

Infections Diagnosis & Treatment, 2012 (%)


5
South Region

2011

2012

2013

2014

Catheterassociated
UTIs, 20.0%

C. Difficile
Infections,
20.0%

Central lineassociated
bloodstream
infection,
20.0%

2010 2011 2012 2013 2014

United States Number of Deaths from


10 Leading Causes, 2013

Ventilatorassociated
Pneumonia, 20.0%

10

United States Hospital-acquired Infections Prevention


Market Size, By Value, 2010-2020F (USD Billion)
11
9 10
8
7
6
5
4
3
2
1

Surgical Site
Infections, 20.0%

United States Hospital-acquired Infections Prevention Market Share, By


Company, By Value, 2010-2020F

31%

31.1% 31.2% 31.3% 31.4% 31.5% 31.6% 31.7% 31.8% 31.9%

32%

16%

16.1% 16.2% 16.3% 16.4% 16.5% 16.6% 16.7% 16.8% 16.9%

17%

14%

14.1% 14.2% 14.3% 14.4% 14.5% 14.6% 14.7% 14.8% 14.9%

15%

5%

5.1%

5.2%

5.3%

5.4%

5.5%

5.6%

5.7%

5.8%

30.1% 30.2% 30.3% 30.4% 30.5% 30.6% 30.7% 30.8% 30.9%


2010

2011

2012

2013

2014

5.9%

6%

31%

31.1%

2015E 2016F 2017F 2018F 2019F 2020F

Others

3M Company

ASP

Steris Corporation

Getinge USA Inc.

10
Pharmaion

Report Ordering

Report Name: United States Hospital-acquired Infections Prevention


Market Opportunities, 2010-2020
Report Price
License Type

Price

Single User License

$2500

Single User License Print

$3000

Enterprise License

$5000

To View Sample OR Purchase Report

11
Pharmaion

About Us & Disclaimer


About Us :
Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.
Pharmaions core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers
with high value market research and advisory services that helps them identify new market opportunities, growth engines and
innovative ways to capture the market share. As a result, Pharmaions clients lead rather than follow market trends. Not bound by
legacy, Pharmaions cutting-edge research model leverages its decades of research knowledge and an increased use of technology as
engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaions reports
do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with
comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industrys best-trained
industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting
requirements.

Related Reports
United States Autoimmune Disorders Diagnostics Market Opportunities, 2020
Global Tissue Engineered Medical Devices Market Opportunities, 2020
Global Cervical Cancer Vaccine Market Opportunities, 2020

Disclaimer :
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made
that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from
various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy or
completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and
especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates
and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for clients
internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.

NORTH AMERICA
Pharmaion Consultants LLC
708 3RD Avenue, 6th Floor, New York, NY,
United State, 10017
sales@pharmaion.com
+1 646 360 1656
www.pharmaion.com

ASIA PACIFIC
Pharmaion Consultants Pvt. Ltd.
A 51, Sector 57, Noida, National Capital Region,
India - 201301
sales@pharmaion.com
+91 - 120 - 452 3900
www.pharmaion.com

12
Pharmaion

S-ar putea să vă placă și